These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19758241)

  • 41. The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies.
    Vecchiarelli A
    Curr Mol Med; 2005 Jun; 5(4):413-20. PubMed ID: 15977997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
    Cherniak R; Morris LC; Belay T; Spitzer ED; Casadevall A
    Infect Immun; 1995 May; 63(5):1899-905. PubMed ID: 7729900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.
    Devi SJ; Schneerson R; Egan W; Ulrich TJ; Bryla D; Robbins JB; Bennett JE
    Infect Immun; 1991 Oct; 59(10):3700-7. PubMed ID: 1716613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.
    Nakouzi A; Zhang T; Oscarson S; Casadevall A
    Vaccine; 2009 Jun; 27(27):3513-8. PubMed ID: 19464529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
    Cleare W; Casadevall A
    Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulated Release of Cryptococcal Polysaccharide Drives Virulence and Suppresses Immune Cell Infiltration into the Central Nervous System.
    Denham ST; Verma S; Reynolds RC; Worne CL; Daugherty JM; Lane TE; Brown JCS
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203547
    [No Abstract]   [Full Text] [Related]  

  • 48. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.
    Sundstrom JB; Cherniak R
    Infect Immun; 1992 Oct; 60(10):4080-7. PubMed ID: 1398921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.
    Ramos CL; Fonseca FL; Rodrigues J; Guimarães AJ; Cinelli LP; Miranda K; Nimrichter L; Casadevall A; Travassos LR; Rodrigues ML
    Eukaryot Cell; 2012 Sep; 11(9):1086-94. PubMed ID: 22562469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
    Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
    Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
    Cleare W; Casadevall A
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):125-9. PubMed ID: 9521132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
    Cleare W; Mukherjee S; Spitzer ED; Casadevall A
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):737-40. PubMed ID: 8556529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
    Fleuridor R; Lees A; Pirofski L
    J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
    Feldmesser M; Casadevall A
    Front Biosci; 1998 Feb; 3():d136-51. PubMed ID: 9445465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.
    Jesus MD; Nicola AM; Chow SK; Lee IR; Nong S; Specht CA; Levitz SM; Casadevall A
    Virulence; 2010; 1(6):500-8. PubMed ID: 21178496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
    Otteson EW; Welch WH; Kozel TR
    J Biol Chem; 1994 Jan; 269(3):1858-64. PubMed ID: 8294434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen.
    Crawford CJ; Guazzelli L; McConnell SA; McCabe O; d'Errico C; Greengo SD; Wear MP; Jedlicka AE; Casadevall A; Oscarson S
    ACS Infect Dis; 2024 Feb; 10(2):475-488. PubMed ID: 37856427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P; Nussbaum G; Oh J; Scharff MD
    J Immunol; 1998 Aug; 161(4):1829-36. PubMed ID: 9712050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans.
    Mukherjee J; Cleare W; Casadevall A
    J Immunol Methods; 1995 Jul; 184(1):139-43. PubMed ID: 7622865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.